Federated Journals
  • Home
  • About
Log in Write Now
Log in Subscribe
  • Home
  • About

k kumar

Hi I'm k kumar
171 posts

The Future of Congenital Heart Defect Devices: Market Growth, Technological Progress, and Emerging Opportunities

If you've been keeping an eye on cardiac device innovation lately, you've probably noticed something: babies born with structural heart problems are getting better, safer treatment options than ever before.

  • Go to the profile of  k kumar
k kumar
13 Sep 2026 · 3 min read

Bullous Pemphigoid Market Evolution: Epidemiological Patterns, Pipeline Therapies, and Commercial Outlook

Picture a disease that mostly shows up late in life, often in patients already juggling several other health conditions, and you've got a good starting point for understanding bullous pemphigoid.

  • Go to the profile of  k kumar
k kumar
13 Sep 2026 · 3 min read

Understanding the Vaccine Adjuvants Market: Market Trends, Major Companies, and Opportunities

Here's something worth paying attention to: the science of making vaccines work better is quietly becoming one of the fastest-growing corners of global healthcare. Between 2024 and 2030, the vaccine

  • Go to the profile of  k kumar
k kumar
13 Sep 2026 · 3 min read

Surgical Sutures Market Forecast and Analysis: Segments, Trends, and Regional Prospects

Wound closure might seem like the least glamorous corner of medtech, but the numbers tell a different story. The surgical sutures market is set to nearly double in less than

  • Go to the profile of  k kumar
k kumar
9 Sep 2026 · 4 min read

Porphyria Targeting Therapies Market Outlook: Emerging Therapies and Competitive Landscape to 2034

Porphyria isn't a single disease — it's a family of rare metabolic disorders, inherited or acquired, that stem from glitches in how the body produces heme, the essential building block of

  • Go to the profile of  k kumar
k kumar
9 Sep 2026 · 3 min read

Rising Pipeline Activity Positions TIGIT Inhibitors as a Key Area in Oncology Research

Cancer immunotherapy has a new name generating buzz beyond PD-1 and PD-L1: TIGIT, short for T-cell immunoreceptor with Ig and ITIM domains. Sitting on the surface of activated T cells,

  • Go to the profile of  k kumar
k kumar
8 Sep 2026 · 3 min read

Pain Management Devices Market: Exploring Growth Trends and Emerging Opportunities

Pain touches almost everyone at some point, but for hundreds of millions of people worldwide it's not a passing inconvenience — it's a daily reality. That's precisely why the pain management

  • Go to the profile of  k kumar
k kumar
8 Sep 2026 · 4 min read

Neurology Devices Market Landscape: Global Developments and Regional Opportunities

The neurology devices market is forecast to expand at a CAGR of 7.46% from 2024 to 2030, a trajectory underpinned by structural demographic and epidemiological shifts rather than short-term

  • Go to the profile of  k kumar
k kumar
6 Sep 2026 · 3 min read

Choroidal Neovascularization Market Outlook: Advancements Driving Market Expansion

Picture a disease that quietly steals the center of someone's vision, injection by injection, year after year. That's the reality for millions living with abnormal vessel growth beneath the retina,

  • Go to the profile of  k kumar
k kumar
6 Sep 2026 · 3 min read

Chronic Lower Back Pain Market: Understanding Growth Drivers, Unmet Needs, and Emerging Drugs

Nearly a third of adults in the US now live with pain that just won't quit — and that reality is reshaping an entire industry. CLBP full form simply refers to

  • Go to the profile of  k kumar
k kumar
6 Sep 2026 · 4 min read

Intratumoral Cancer Therapies Market: Competitive Landscape and Emerging Therapeutic Strategies

Intratumoral cancer treatment works on a simple but powerful premise: deliver the therapeutic agent straight into the tumor rather than sending it through the entire bloodstream. This targeted route reduces

  • Go to the profile of  k kumar
k kumar
30 Aug 2026 · 3 min read

Future of GLP-1 Agonists: Market Expansion, Therapeutic Innovation, and Competitive Trends Through 2036

The glucagon-like peptide-1 agonists market is currently ruled by two names — Eli Lilly and Novo Nordisk — who together hold close to 94% of global share. That kind of concentration makes

  • Go to the profile of  k kumar
k kumar
30 Aug 2026 · 3 min read

The Rising Obesity Treatment Landscape: GLP-1 Therapies and Market Growth Ahead

Obesity care is undergoing a dramatic transformation, and nowhere is this more visible than in the pace of change sweeping through the pharmaceutical pipeline. From oral incretin therapies to next-generation

  • Go to the profile of  k kumar
k kumar
27 Aug 2026 · 3 min read

Global Type 2 Diabetes Treatment Market: Current Landscape and Long-Term Growth Potential

Type 2 Diabetes is a chronic, progressive metabolic disorder characterized by insulin resistance and inadequate insulin secretion, resulting in persistently elevated blood glucose and a heightened risk of microvascular and

  • Go to the profile of  k kumar
k kumar
27 Aug 2026 · 3 min read

Transforming Chronic Pain Care: Market Dynamics, Therapies, and Future Outlook

Persistent and recurring pain conditions continue to place a heavy burden on healthcare systems across the 7MM (the US, EU4, the UK, and Japan). Valued at nearly USD 12 billion

  • Go to the profile of  k kumar
k kumar
26 Aug 2026 · 3 min read

Exploring the Chronic Kidney Disease Market: Trends, Drug Development, and Market Potential

Across the seven major markets (7MM) — the US, EU4 (Germany, France, Italy, Spain), the UK, and Japan — the chronic kidney disease market size was valued at approximately USD 5 billion

  • Go to the profile of  k kumar
k kumar
26 Aug 2026 · 3 min read

Progeria Market Insights: Prevalence, Incidence, Treatment Landscape, and Future Outlook

Progeria is a group of ultra-rare genetic disorders marked by dramatically accelerated aging, and interest in the disease has grown alongside rising diagnostic awareness and expanding research investment. Although the

  • Go to the profile of  k kumar
k kumar
25 Aug 2026 · 4 min read

The Rising Role of Exosome Therapeutics: Market Dynamics and Pipeline Developments 2025–2034

Extracellular vesicles have moved from lab curiosity to a genuine drug-development category. The exosomes market now spans oncology, neurology, dermatology, and regenerative medicine, with the current forecast window running 2025

  • Go to the profile of  k kumar
k kumar
25 Aug 2026 · 3 min read
Federated Journals
© 2026 Federated Journals. All rights reserved.
Design with by @GodoFredoNinja
No results found
    ↑ ↓ Navigate up/down
    Enter Go to article
    Esc Close search